Abstract
Striatal dopamine (DA) of rats increased twofold 1 h after blockade of DA release by either an electrolytic lesion of the substantia nigra (SN) or systemic administration of 1-hydroxy-3-amino-pyrrolidone-2 (HA-966). If the treatments were combined, no further increase was observed. The decrease in DA induced by alpha-methyl-p-tyrosine (alphaMT) in otherwise untreated animals was not enhanced by a 20 min electrical stimulation of nigrostriatal fibres. If, however, in addition to synthesis blockade by alphaMT, DA release was interrupted by a lesion of the SN and/or by HA-966, electrical stimulation caused a significant decrease in striatal DA. It is assumed that HA-966 exerts its action in the dopaminergic nigrostriatal system by way of blockade of the nerve impulse flow at the level of the SN.
References
Oct 12, 1976·Naunyn-Schmiedeberg's Archives of Pharmacology·L C Murrin, R H Roth
Jan 1, 1976·Pharmacology & Therapeutics. Part B: General & Systematic Pharmacology·M GoldsteinB Anagnoste
Sep 1, 1975·European Journal of Pharmacology·B J Van Zwieten-Boot, E L Noach
Jan 1, 1976·Pharmacology & Therapeutics. Part B: General & Systematic Pharmacology·R H Roth
Jul 1, 1971·European Journal of Pharmacology·N E AndénU Ungerstedt
Sep 14, 1973·Brain Research·J Davies, J C Watkins
Jul 1, 1971·Journal of Neurochemistry·F Javoy, J Glowinski
Mar 15, 1972·Experientia·N E AndénU Ungerstedt
Jul 5, 1974·Brain Research·Y AgidJ Glowimski
Nov 1, 1971·British Journal of Pharmacology·I L BontaA W Sim
Feb 1, 1971·Archives Internationales De Pharmacodynamie Et De Thérapie·F C Hillen, E L Noach
Feb 1, 1971·Analytical Biochemistry·M K Shellenberger, J H Gordon
Mar 1, 1969·Experimental Neurology·R L Faull, R Laverty
Oct 1, 1953·Journal of Neuropathology and Experimental Neurology·H KLUVER, E BARRERA
Feb 11, 1963·Acta Neuropathologica·E TANI, S ISHII
Jul 12, 1972·Nature: New Biology·J Davies, J C Watkins
Citations
Jan 1, 1992·Journal of Neural Transmission. General Section·B A McMillenP D Shepard
Dec 7, 1979·European Journal of Pharmacology·H J BroxtermanC F Van Valkenburg
Aug 1, 1979·European Journal of Pharmacology·C F Van ValkenburgA Wijling
Oct 4, 1995·European Journal of Pharmacology·P D ShepardK C Grobaski
Apr 1, 1983·Physiology & Behavior·G G Dougherty, E H Ellinwood
Jan 1, 1980·The Journal of Pharmacy and Pharmacology·H J BroxtermanE L Noach